Top

Annals of Surgical Oncology

Published in:

01-11-2016 | Thoracic Oncology

Prognostic Significance of Lymphovascular Invasion for Thoracic Esophageal Squamous Cell Carcinoma

Authors: Shaohua Wang, MD, Xiaofeng Chen, MD, Jie Fan, MD, Lu Lu, MD

Published in: Annals of Surgical Oncology | Issue 12/2016

Abstract

Objectives

This study was designed to demonstrated the prognostic significance of lymphatic and vascular invasion in thoracic esophageal squamous cell carcinoma after curative surgery and establish their predictive role for lymph node metastasis and recurrence in early-stage disease.

Methods

Clinical data of all patients from 2002 to 2014 who underwent curative surgery for thoracic squamous cell carcinoma were collected from a prospectively maintained database. The association of lymphatic invasion and vascular invasion with clinicopathological variables was illustrated respectively. The effect of lymphatic invasion and vascular invasion on the disease-free survival was determined by Kaplan–Meier analysis stratified by pathological stage. The predictive factors for lymph node metastasis in pT1 tumors and the predictive factors for recurrence in patients without lymph node involvement were analyzed with univariate and multivariate analyses respectively.

Results

Both lymphatic invasion and vascular invasion significantly decreased stage-stratified, disease-free survival (p < 0.001). The independent predictive factors for lymph node metastasis in tumors limited in mucosa and submucosa were: submucosa invasion (p < 0.001, odds ratio [OR] 7.303), lymphatic invasion (p < 0.001, OR 5.031), and tumor differentiation (p = 0.008, OR 1.784). The independent predictive factors for decreased disease-free survival in patients with N0 disease involvement were: lymphatic invasion (p = 0.005, OR 4.326) and deeper tumor invasion (p = 0.001, OR 2.634).

Conclusions

Lymphatic invasion and vascular invasion are negative prognostic factors independent of tumor stage. Lymphatic invasion is a high-risk factor of lymph node metastasis in T1 tumors and a high-risk factor of recurrence in patients without lymph node involvement.

Tanaka T, Matono S, Nagano T, et al. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors. Ann Surg Oncol. 2011;19:750–6.CrossRefPubMed

Kunisaki C, Makino H, Takagawa R, et al. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg. 2007;12:802–10.CrossRefPubMed

Zafirellis K, Dolan K, Fountoulakis A, et al. Multivariable analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus. 2002;15:155–9.CrossRefPubMed

Schoppmann SF, Jesch B, Zacherl J, Riegler MF, Friedrich J, Birner P. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer. Surgery. 2013;153:526–34.CrossRefPubMed

Tanaka T, Matona S, Mori N, et al. T1 Squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy. Ann Surg Oncol. 2014;21(3):932–8.CrossRefPubMed

Bai B, Ma W, Wang K, et al. Detection of D2–40 monoclonal antibody-labeled lymphatic vessel invasion in esophageal squamous cell carcinoma and its clinicopathologic significance. Cancer Biol Med. 2013;10:81–5.PubMedPubMedCentral

Waraich N, Rashid F, Jan A, et al. Vascular invasion is not a risk factor in oesophageal cancer recurrence. Int J Surg. 2011; 9:237–40.CrossRefPubMed

Perry C, Soomro I, Kaye P, et al. Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication. Dis Esophagus. 2015;28(3):262–8.CrossRefPubMed

Matsubara T, Ueda M, Abe T, et al. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus. Br J Surg. 1999;86:669–73.CrossRefPubMed

10.

Endo M, Yoshino K, Kawano T, et al. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus. 2000;13:125–9.CrossRefPubMed

11.

Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–80.CrossRefPubMed

12.

Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–5.CrossRefPubMed

13.

Fujita H, Sueyoshi S, Yamana H, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg. 2001;25:424–31.CrossRefPubMed

14.

Mitobe J, Ikogami M, Urashima M, et al. Clinicopathological investigation of lymph node metastasis predictors in superficial esophageal squamous cell carcinoma with a focus on evaluation of lympho-vascular invasion. Scand J Gastroenterol. 2013;48(10):1173–82.CrossRefPubMed

15.

Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol. 2003;21(24):4592–6.CrossRefPubMed

16.

Lee J, Lee KE, Im YH, et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2005;80(4):1170–5.CrossRefPubMed

17.

Shiozaki A, Yamagishi H, Itoi H, et al. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer. Oncol Rep 2005;13(4):667–72.PubMed

18.

Huang Q, Luo K, Chen C, et al. Identification and validation of lymphovascular invasion as a prognostic and staging factor in node-negative esophageal squamous cell carcinoma. J Thorac Oncol. 2016;11(4):583–92.CrossRefPubMed

19.

Imamura Y, Watanabe M, Nagai Y, et al. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma. J Surg Oncol. 2012;105(3):277–83.CrossRefPubMed

Title: Prognostic Significance of Lymphovascular Invasion for Thoracic Esophageal Squamous Cell Carcinoma
Authors: Shaohua Wang, MD
Xiaofeng Chen, MD
Jie Fan, MD
Lu Lu, MD
Publication date: 01-11-2016
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue 12/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-016-5416-8

ACC 2024 Congress

Springer Medicine

Prognostic Significance of Lymphovascular Invasion for Thoracic Esophageal Squamous Cell Carcinoma

Abstract

Objectives

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2016

Mucocele-Like Lesions of the Breast: Rate of Upstaging and Cancer Development

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis

Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy

Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma

PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy

Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer